Aligning Tumor Mutational Burden (TMB) quantification across diagnostic platforms
Literature
Read More
Talking Cancer: Conversations with Trailblazers, Advocates, Patients, and Medical Ambassadors
Blog
Read More
NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR™ MRD and InVisionFirst®-Lung Assays at the ESMO Congress 2021
Press Release
Read More
NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
Press Release
Read More
EZH2 expression is associated with inferior overall survival in mantle cell lymphoma
Literature
Read More